As well as potentially reducing insulin resistance and improving glycaemic control [103], this diet results in a degree of ketosis on its own, and as a result, the continuation of SGLT2 inhibitors in people with diabetes mellitus could lead to significant ketoacidosis [103, 104]. This evidence concerns the gene SLC5A2 and diabetes mellitus.